<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28161392</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1695-9531</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Anales de pediatria (Barcelona, Spain : 2003)</Title><ISOAbbreviation>An Pediatr (Barc)</ISOAbbreviation></Journal><ArticleTitle>[Recommendations for the diagnosis and treatment of classic forms of 21-hydroxylase-deficient congenital adrenal hyperplasia].</ArticleTitle><Pagination><StartPage>116.e1</StartPage><EndPage>116.e10</EndPage><MedlinePgn>116.e1-116.e10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anpedi.2016.12.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1695-4033(16)30339-3</ELocationID><Abstract><AbstractText>Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is an autosomal recessive disorder caused by mutations in the CYP21A2 gene. Cortisol and aldosterone synthesis are impaired in the classic forms (adrenal insufficiency and salt-wasting crisis). Females affected are virilised at birth, and are at risk for genital ambiguity. In this article we give recommendations for an early as possible diagnosis and an appropriate and individualised treatment. A patient and family genetic study is essential for the diagnosis of the patient, and allows genetic counselling, as well as a prenatal diagnosis and treatment for future pregnancy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Asociaci&#xf3;n Espa&#xf1;ola de Pediatr&#xed;a. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr&#xed;guez</LastName><ForeName>Amparo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Espa&#xf1;a. Electronic address: amparorodriguezsanchez@yahoo.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezquieta</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n para Investigaci&#xf3;n Gregorio Mara&#xf1;&#xf3;n, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labarta</LastName><ForeName>Jos&#xe9; Igancio</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Hospital Universitario Miguel Servet, Zaragoza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clemente</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Vall d'Hebron, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espino</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario Valme, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Amaia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Cruces, Barakaldo, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escribano</LastName><ForeName>Aranzazu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario Virgen Arrixaca, Murcia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>en representaci&#xf3;n del grupo de Hiperplasia Suprarrenal Cong&#xe9;nita de la Sociedad Espa&#xf1;ola de Endocrinolog&#xed;a Pedi&#xe1;trica</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><VernacularTitle>Recomendaciones para el diagn&#xf3;stico y tratamiento de pacientes con formas cl&#xe1;sicas de hiperplasia suprarrenal cong&#xe9;nita por d&#xe9;ficit de 21-hidroxilasa.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>An Pediatr (Barc)</MedlineTA><NlmUniqueID>101162596</NlmUniqueID><ISSNLinking>1695-4033</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C535979">Congenital adrenal hyperplasia due to 21 hydroxylase deficiency</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000312" MajorTopicYN="N">Adrenal Hyperplasia, Congenital</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">21-hydroxylase deficiency</Keyword><Keyword MajorTopicYN="N">Congenital adrenal hyperplasia</Keyword><Keyword MajorTopicYN="N">D&#xe9;ficit de 21-hidroxilasa</Keyword><Keyword MajorTopicYN="N">Genital ambiguity</Keyword><Keyword MajorTopicYN="N">Genitales ambiguos</Keyword><Keyword MajorTopicYN="N">Hiperplasia suprarrenal cong&#xe9;nita</Keyword><Keyword MajorTopicYN="N">P&#xe9;rdida salina</Keyword><Keyword MajorTopicYN="N">Salt-wasting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28161392</ArticleId><ArticleId IdType="doi">10.1016/j.anpedi.2016.12.002</ArticleId><ArticleId IdType="pii">S1695-4033(16)30339-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27821898</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1657-9534</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Colombia medica (Cali, Colombia)</Title><ISOAbbreviation>Colomb Med (Cali)</ISOAbbreviation></Journal><ArticleTitle>Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: description of a new mutation, R384X.</ArticleTitle><Pagination><StartPage>172</StartPage><EndPage>175</EndPage><MedlinePgn>172-175</MedlinePgn></Pagination><Abstract><AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">It is presented the phenotype of a new compound heterozygous mutation of the genes R384X and Q356X encoding the enzyme of 11-beta-hydroxylase.</AbstractText><AbstractText Label="CLINICAL FINDINGS" NlmCategory="RESULTS">Severe virilization, peripheral hypertension, and early puberty.</AbstractText><AbstractText Label="TREATMENT AND OUTCOME" NlmCategory="RESULTS">Managed with hormone replacement therapy (corticosteroid) and antihypertensive therapy (beta-blocker), resulting in the control of physical changes and levels of arterial tension.</AbstractText><AbstractText Label="CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">According to the phenotypic characteristics of the patient, it is inferred that the <i>R384X</i> mutation carries an additional burden on the <i>Q356X</i> mutation, with the latter previously described as a cause of 11-beta-hydroxylase deficiency. The description of a new genotype, as in this case, expands the understanding of the hereditary burden and deciphers the various factors that lead to this pathology as well as the other forms of congenital adrenal hyperplasia (CAH), presenting with a broad spectrum of clinical presentations. This study highlights the importance of a complete description of the patient's CAH genetic profile as well as their parents' genetic profile.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matallana-Rhoades</LastName><ForeName>Audrey Mary</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Instituto Cisalva, Universidad del Valle, Cali, Colombia; Fundaci&#xf3;n SCISCO, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corredor-Castro</LastName><ForeName>Juan David</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Instituto Cisalva, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla-Escobar</LastName><ForeName>Francisco Javier</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Universidad del Valle, Cali, Colombia; Hospital Universitario del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mecias-Cruz</LastName><ForeName>Bony Valentina</ForeName><Initials>BV</Initials><AffiliationInfo><Affiliation>Instituto Cisalva, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mejia de Beldjena</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Cl&#xed;nica Valle del Lili, Cali, Colombia; Fundaci&#xf3;n Cl&#xed;nica Infantil Club Noel, Cali, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Colomb Med (Cali)</MedlineTA><NlmUniqueID>9212578</NlmUniqueID><ISSNLinking>0120-8322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003062">Codon</NameOfSubstance></Chemical><Chemical><RegistryNumber>6E0A168OB8</RegistryNumber><NameOfSubstance UI="D064791">Desoxycorticosterone Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.15.4</RegistryNumber><NameOfSubstance UI="D013252">Steroid 11-beta-Hydroxylase</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C535978">Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000312" MajorTopicYN="N">Adrenal Hyperplasia, Congenital</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002898" MajorTopicYN="N">Chromosomes, Human, Pair 8</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003062" MajorTopicYN="N">Codon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064791" MajorTopicYN="N">Desoxycorticosterone Acetate</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059785" MajorTopicYN="N">Karyotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013252" MajorTopicYN="N">Steroid 11-beta-Hydroxylase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014770" MajorTopicYN="N">Virilism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="DESCRIPCI&#xd3;N DEL CASO" NlmCategory="UNASSIGNED">Se presenta el fenotipo de una nueva mutaci&#xf3;n heterocigota compuesta en los genes Q356X y R384X que codifican la enzima 11-beta-hidroxilada.</AbstractText><AbstractText Label="HALLAZGOS CL&#xcd;NICOS" NlmCategory="UNASSIGNED">Virilizaci&#xf3;n severa, pubertad precoz perif&#xe9;rica e hipertensi&#xf3;n.</AbstractText><AbstractText Label="TRATAMIENTO Y RESULTADOS" NlmCategory="UNASSIGNED">Manejo con terapia de reemplazo hormonal con corticoide y antihipertensivo con beta-bloqueador con lo que se logr&#xf3; controlar los cambios f&#xed;sicos y los niveles de tensi&#xf3;n arterial.</AbstractText><AbstractText Label="RELEVANCIA CL&#xcd;NICA" NlmCategory="UNASSIGNED">Seg&#xfa;n las caracter&#xed;sticas fenot&#xed;picas del paciente se infiere que la mutaci&#xf3;n R384X acarrea una carga adicional a la mutaci&#xf3;n Q356X, esta &#xfa;ltima descrita como causa de deficiencia de 11-beta-hidroxilasa. La descripci&#xf3;n de nuevos genotipos, como en este caso, permite ampliar la comprensi&#xf3;n de la carga hereditaria y descifrar los diversos factores que llevan a que esta patolog&#xed;a, as&#xed; como las dem&#xe1;s formas de hiperplasia suprarrenal cong&#xe9;nita (HSC), se presenten con un amplio espectro de cuadros cl&#xed;nicos. Esto permite resaltar la importancia de una descripci&#xf3;n completa del perfil gen&#xe9;tico del paciente con HSC y de sus padres.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="DESCRIPCI&#xd3;N DEL CASO:">Se presenta el fenotipo de una nueva mutaci&#xf3;n heterocigota compuesta en los genes Q356X y R384X que codifican la enzima 11-beta-hidroxilada</AbstractText><AbstractText Label="HALLAZGOS CL&#xcd;NICOS:">Virilizaci&#xf3;n severa, pubertad precoz perif&#xe9;rica e hipertensi&#xf3;n.</AbstractText><AbstractText Label="TRATAMIENTO Y RESULTADOS:">Manejo con terapia de reemplazo hormonal con corticoide y antihipertensivo con beta-bloqueador con lo que se logr&#xf3; controlar los cambios f&#xed;sicos y los niveles de tensi&#xf3;n arterial.</AbstractText><AbstractText Label="RELEVANCIA CL&#xcd;NICA:">Seg&#xfa;n las caracter&#xed;sticas fenot&#xed;picas del paciente se infiere que la mutaci&#xf3;n R384X acarrea una carga adicional a la mutaci&#xf3;n Q356X, esta &#xfa;ltima descrita como causa de deficiencia de 11-beta-hidroxilasa. La descripci&#xf3;n de nuevos genotipos, como en este caso, permite ampliar la comprensi&#xf3;n de la carga hereditaria y descifrar los diversos factores que llevan a que esta patolog&#xed;a, as&#xed; como las dem&#xe1;s formas de hiperplasia suprarrenal cong&#xe9;nita (HSC), se presenten con un amplio espectro de cuadros cl&#xed;nicos. Esto permite resaltar la importancia de una descripci&#xf3;n completa del perfil gen&#xe9;tico del paciente con HSC y de sus padres.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">11-beta-hydroxylase deficiency</Keyword><Keyword MajorTopicYN="Y">Adrenal hyperplasia congenital</Keyword><Keyword MajorTopicYN="Y">Virilism</Keyword><Keyword MajorTopicYN="Y">adrenocorticotropic hormone</Keyword><Keyword MajorTopicYN="Y">hyperplasia adrenal glands</Keyword><Keyword MajorTopicYN="Y">mutation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27821898</ArticleId><ArticleId IdType="pmc">PMC5091277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nimkarn S, New MI. Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab. 2008;19(3):96&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">18294861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983;56(2):222&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">6296182</ArticleId></ArticleIdList></Reference><Reference><Citation>Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA. 1993;90(10):4552&#x2013;4556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46550</ArticleId><ArticleId IdType="pubmed">8506298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC. Cloning of cDNA encoding steroid 11-beta-hydroxylase (P450c11) Proc Natl Acad Sci USA. 1987;84(20):7193&#x2013;7197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299256</ArticleId><ArticleId IdType="pubmed">3499608</ArticleId></ArticleIdList></Reference><Reference><Citation>Paperna T, Gershoni-Baruch R, Badarneh K, Kasinetz L, Hochberg Z. Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews. J Clin Endocrinol Metab. 2005;90(9):5463&#x2013;5465.</Citation><ArticleIdList><ArticleId IdType="pubmed">16030166</ArticleId></ArticleIdList></Reference><Reference><Citation>Soardi FC, Penachioni JY, Justo GZ, Bachega TA, In&#xe1;cio M, Mendon&#xe7;a BB, et al. Novel mutations in CYP11B1 gene leading to 11&#xdf;-hydroxylase deficiency in Brazilian patients. J Clin Endocrinol Metab. 2009;94(9):3481&#x2013;3485.</Citation><ArticleIdList><ArticleId IdType="pubmed">19567537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrat M, Trabelsi S, Chaabouni M, Maazoul F, Kraoua L, Ben Jemaa L, et al. Only two mutations detected in 15 Tunisian patients with 11&#xdf;-hydroxylase deficiency: the p.Q356X and the novel p.G379V. Clin Genet. 2010;78(4):1399&#x2013;1401.</Citation><ArticleIdList><ArticleId IdType="pubmed">20331679</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumic K, Yuen T, Grubic Z, Kusec V, Barisic I, New MI. Two novel CYP11B1 gene mutations in patients from two croatian families with 11&#xdf;-hydroxylase deficiency. Int J Endocrinol. 2014;2014(2014):185974&#x2013;185974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060432</ArticleId><ArticleId IdType="pubmed">24987415</ArticleId></ArticleIdList></Reference><Reference><Citation>Antal Z, Zhou P. Congenital Adrenal Hyperplasia: Diagnosis, evaluation, and management. Pediatr Rev. 2009;30(7):e49&#x2013;e57.</Citation><ArticleIdList><ArticleId IdType="pubmed">19570920</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter M. Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency. Semin Reprod Med. 2002;20(3):249&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">12428205</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisch N, H&#xf6;gler W, Parajes S, Rose IT, Dhir V, G&#xf6;tzinger J, et al. A diagnosis not to be missed: Non-classic steroid 11&#xdf;-hydroxylase deficiency presenting with premature adrenarche and hirsutism. J Clin Endocrinol Metab. 2013;98(10):1620&#x2013;1625.</Citation><ArticleIdList><ArticleId IdType="pubmed">23940125</ArticleId></ArticleIdList></Reference><Reference><Citation>German A, Suraiya S, Tenenbaum-Rakover Y, Koren I, Pillar G, Hochberg Z. Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy. J Clin Endocrinol Metab. 2008;93(12):470710&#x2013;470710.</Citation><ArticleIdList><ArticleId IdType="pubmed">18782876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19080859</PMID><DateCompleted><Year>2009</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-7753</ISSN><JournalIssue CitedMedium="Print"><Volume>131</Volume><Issue>16</Issue><PubDate><Year>2008</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Medicina clinica</Title><ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation></Journal><ArticleTitle>[Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency presenting with erythrocytosis].</ArticleTitle><Pagination><StartPage>638</StartPage><EndPage>639</EndPage><MedlinePgn>638-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Regadera</LastName><ForeName>Anabel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rom&#xe1;n</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ezquieta</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><VernacularTitle>Poliglobulia como forma de presentaci&#xf3;n de hiperplasia suprarrenal cong&#xe9;nita por d&#xe9;ficit de 21-hidroxilasa.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Barc)</MedlineTA><NlmUniqueID>0376377</NlmUniqueID><ISSNLinking>0025-7753</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.14.14.16</RegistryNumber><NameOfSubstance UI="D013255">Steroid 21-Hydroxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000312" MajorTopicYN="N">Adrenal Hyperplasia, Congenital</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011086" MajorTopicYN="N">Polycythemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013255" MajorTopicYN="N">Steroid 21-Hydroxylase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>2</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19080859</ArticleId><ArticleId IdType="doi">10.1157/13127927</ArticleId><ArticleId IdType="pii">13127927</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9379733</PMID><DateCompleted><Year>1997</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-7753</ISSN><JournalIssue CitedMedium="Print"><Volume>109</Volume><Issue>11</Issue><PubDate><Year>1997</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicina clinica</Title><ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation></Journal><ArticleTitle>[Characterization of steroid 21-hydroxylase gene mutations in a oligosymptomatic form of congenital adrenal hyperplasia: family study].</ArticleTitle><Pagination><StartPage>421</StartPage><EndPage>424</EndPage><MedlinePgn>421-4</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">21-hydroxilase deficiency accounts for over 90% of all cases of congenital adrenal hyperplasia (CAH). There is a non-negligible incidence of both severe and nonclassical forms of this genetic disorder. Enzyme deficiency is due to mutations in the gene encoding adrenal 21-hydroxylase (named CYP 21B) and is inherited in an autosomical recesive way. Complete or partial impairment of enzyme activity has been correlated with the different clinical forms of the disease.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">In the present paper CYP 21B gene analysis results obtained in a family with two kindred affected by a nonclassical form of the disease are shown. Clinical assessment of these two kindred showed a very mild form of the disease, whereas biochemical results suggested a late-onset partial 21-hydroxylase deficiency. Genotyping for deletions and 10 point mutations in the CYP 21B gene was performed by Southern blot analysis and polymerase chain reaction (PCR) allele-specific oligonucleotide (ASO) hybridation technique.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Molecular genetic analysis performed in the two affected patients and two further relatives allowed us to detect the presence of different mutations in the two alleles of the CYP 21B gene. One of these mutations was severe (655G) and came from maternal line, whereas the other was mild (Val281Leu) and originated in paternal line.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Molecular genetic analysis allows the possibility of finding severe (and non-expected) mutations in patients with clinically mild and late-onset forms of the 21-hydroxylase deficiency.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;nez Olmos</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitario La Paz, Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Ezquieta</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Hillman</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>D&#xed;ez</LastName><ForeName>J J</ForeName><Initials>JJ</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Caracterizaci&#xf3;n de las mutaciones del gen de la esteroide 21-hidroxilasa en una forma oligosintom&#xe1;tica de hiperplasia suprarrenal cong&#xe9;nita: estudio familiar.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Barc)</MedlineTA><NlmUniqueID>0376377</NlmUniqueID><ISSNLinking>0025-7753</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.14.14.16</RegistryNumber><NameOfSubstance UI="D013255">Steroid 21-Hydroxylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000312" MajorTopicYN="N">Adrenal Hyperplasia, Congenital</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013255" MajorTopicYN="N">Steroid 21-Hydroxylase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1998</Year><Month>2</Month><Day>12</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1998</Year><Month>2</Month><Day>12</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9379733</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1321317</PMID><DateCompleted><Year>1992</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-7753</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>3</Issue><PubDate><Year>1992</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Medicina clinica</Title><ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation></Journal><ArticleTitle>[A genetic and hormonal study of 5 patients with the nonclassical form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency].</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>86</EndPage><MedlinePgn>81-6</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To study the association between the 21-hydroxylase deficiency with the HLA histocompatibility complex in a mediterranean ethnic group.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">5 patients with late-onset 21-hydroxylase deficiency, diagnosed on the basis of a high plasma level of 17-hydroxyprogesterone, along with 23 family members were typed. 17-hydroxyprogesterone response to iv ACTH stimulus was measured too in the family members.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found a genetic linkage disequilibrium between the late-onset 21-hydroxylase deficiency and the HLA antigen B51. Moreover, similar biologic profiles were observed in the patients and those of their siblings who were HLA identical. The heterozygous carriers showed a intermediate 17-hydroxyprogesterone response to ACTH between propositus and homozygotes and their family members who had no HLA haplotype identical to those of the propositus.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These observations tend to confirm that a close linkage exits between the gene (or genes) for 21-hydroxylase deficiency in late-onset adrenal hyperplasia and the HLA genes. This association may change in the different ethnic groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Unidad de Endocrinolog&#xed;a, Hospital General d'Alacant, Alicante.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pic&#xf3;</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Mauri</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>de la Sen</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Estudio gen&#xe9;tico y hormonal de 5 pacientes afectados de la forma no cl&#xe1;sica de hiperplasia suprarrenal cong&#xe9;nita por d&#xe9;ficit de 21-hidroxilasa.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Barc)</MedlineTA><NlmUniqueID>0376377</NlmUniqueID><ISSNLinking>0025-7753</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006728">Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006908">Hydroxyprogesterones</NameOfSubstance></Chemical><Chemical><RegistryNumber>68-96-2</RegistryNumber><NameOfSubstance UI="D019326">17-alpha-Hydroxyprogesterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-60-2</RegistryNumber><NameOfSubstance UI="D000324">Adrenocorticotropic Hormone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019326" MajorTopicYN="N">17-alpha-Hydroxyprogesterone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000312" MajorTopicYN="Y">Adrenal Hyperplasia, Congenital</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000324" MajorTopicYN="N">Adrenocorticotropic Hormone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006580" MajorTopicYN="N">Genetic Carrier Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006728" MajorTopicYN="N">Hormones</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006908" MajorTopicYN="N">Hydroxyprogesterones</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>6</Month><Day>13</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>6</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1321317</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>